Upregulated ATG4B predicts poor prognosis and correlates with angiogenesis in osteosarcoma
Background Osteosarcoma (OS) is the most common primary bone cancer in children and adolescents. Between 35 and 45% of these patients do not respond to standard chemotherapeutic treatments, resulting in a very low 5-year survival rate of only 5–20%. This resistance often leads to treatment failure a...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-04-01
|
| Series: | Journal of the Egyptian National Cancer Institute |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s43046-025-00269-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|